期刊
PHARMACEUTICS
卷 13, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics13010090
关键词
nanotechnology; mitochondria; respiration; mtDNA deletions; copy number; metals
资金
- government of Asturias through the Science, Technology and Innovation Plan (PCTI) - FEDER funds [FC-GRUPIN-IDI/2018/000242]
- Spanish Ministry of Economy, Industry and Competitiveness (MINECO) [CTQ2016-80069-C 2-1R, RTI2018-094605-B-I00]
The application of metallic nanoparticles as a therapeutic tool can improve the diagnosis and treatment of diseases by targeting mitochondria, affecting cellular function, and triggering autophagy processes. Nanoparticles have the potential to be used as therapeutic agents for cancer and other diseases dependent on mitochondria.
The application of metallic nanoparticles (materials with size at least in one dimension ranging from 1 to 100 nm) as a new therapeutic tool will improve the diagnosis and treatment of diseases. The mitochondria could be a therapeutic target to treat pathologies whose origin lies in mitochondrial dysfunctions or whose progression is dependent on mitochondrial function. We aimed to study the subcellular distribution of 2-4 nm iron nanoparticles and its effect on mitochondrial DNA (mtDNA), mitochondrial function, and autophagy in colorectal cell lines (HT-29). Results showed that when cells were exposed to ultra-small iron nanoparticles, their subcellular fate was mainly mitochondria, affecting its respiratory and glycolytic parameters, inducing the migration of the cellular state towards quiescence, and promoting and triggering the autophagic process. These effects support the potential use of nanoparticles as therapeutic agents using mitochondria as a target for cancer and other treatments for mitochondria-dependent pathologies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据